Please use this identifier to cite or link to this item:
metadata.artigo.dc.title: Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox
metadata.artigo.dc.creator: Guimarães, Ana P.
Souza, Felipe R. de
Oliveira, Aline A.
Gonçalves, Arlan S.
Alencastro, Ricardo B. de
Ramalho, Teodorico C.
França, Tanos C. C.
metadata.artigo.dc.subject: Variola virus
Thymidylate kinase
Molecular dynamics
metadata.artigo.dc.publisher: Elsevier Feb-2015
metadata.artigo.dc.identifier.citation: GUIMARÃES, A. P. et al. Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox. European Journal of Medicinal Chemistry, [S.l.], v. 91, p. 72-90, Feb. 2015. DOI: 10.1016/j.ejmech.2014.09.099.
metadata.artigo.dc.description.abstract: Recently we constructed a homology model of the enzyme thymidylate kinase from Variola virus (VarTMPK) and proposed it as a new target to the drug design against smallpox. In the present work, we used the antivirals cidofovir and acyclovir as reference compounds to choose eleven compounds as leads to the drug design of inhibitors for VarTMPK. Docking and molecular dynamics (MD) studies of the interactions of these compounds inside VarTMPK and human TMPK (HssTMPK) suggest that they compete for the binding region of the substrate and were used to propose the structures of ten new inhibitors for VarTMPK. Further docking and MD simulations of these compounds, inside VarTMPK and HssTMPK, suggest that nine among ten are potential selective inhibitors of VarTMPK.
metadata.artigo.dc.language: en_US
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.